FilingSEC EDGAR8-K
Karyopharm Therapeutics Extends Forbearance Period to October 22
· SEC accepted
StageDebt Forbearance
Filing content
The company and applicable parties agreed to extend the forbearance period from October 15, 2026, to October 22, 2026.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…